Submitted by Anonymous (not verified) on 30 January 2024 - 15:30
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 37, Status: Authorised
Source: